The Influenza Vaccines Market Is Estimated To Witness High Growth Owing To Increasing Adoption of Seasonal Influenza Vaccination

https://www.coherentmarketinsights.com/market-insight/influenza-vaccines-market-1705
Influenza Vaccines Market 


The global Influenza Vaccines Market Share is estimated to be valued at US$ 6216.47 Mn in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:


Influenza vaccines help prevent influenza (flu) by causing the body's immune system to produce antibodies. Vaccination is recommended for health care professionals, adults over age 50, pregnant women, children aged 6 months to 4 years, and individuals with conditions that increase their risk of flu-related complications.

Market key trends:

One of the key trends in the influenza vaccines market is the development of quadrivalent vaccines. Quadrivalent vaccines protect against two influenza A strains and two influenza B strains. These vaccines provide broader protection as compared to trivalent vaccines, which protect against two influenza A strains and one influenza B strain. Quadrivalent vaccines reduce the chances of a mismatch between the circulating influenza B strain and the one in the trivalent vaccine. This helps improve vaccine effectiveness. Another key trend is the development of high-dose vaccines for elderly population. Due to aging of immune system, high-dose vaccines containing higher amount of antigen stimulates better immune response in elderly. This leads to greater vaccine effectiveness in this demographic.


Influenza Vaccines Market Segment Analysis
The global influenza vaccines market is segmented by product type, technology, age group, and distribution channel. Based on product type, the quadrivalent vaccines segment dominated the market in 2022 and is expected to maintain its dominance over the forecast period. Quadrivalent vaccines protect against four different strains of influenza virus including two A strains and two B strains. This provides broader protection and greater efficacy compared to trivalent vaccines.

Key Takeaways
The global influenza vaccines market is expected to witness high growth, exhibiting a CAGR of 4.2% over the forecast period, due to increasing influenza disease prevalence globally coupled with rising vaccination rates.

Regional analysis: North America dominated the global influenza vaccines market in 2022 and is expected to maintain its position during the forecast period. This is attributed to high awareness regarding influenza vaccination and provision of universal vaccination programs in the region. Asia Pacific is expected to grow at the fastest rate owing to large population base, economic development, and improvement in healthcare infrastructure and facilities.

Key players: Key players operating in the influenza vaccines market are Seqirus, GlaxoSmithKline plc, Sanofi, AstraZeneca, FluGen, Inc., Moderna, Inc., Biocryst Pharmaceuticals, Inc., CPL Biologicals Pvt. Ltd., CureVac AG, OSIVAX, and Solaris Vaccines. Major players are focusing on new product launches, geographic expansion, and collaborations to gain market share.

Read More: https://www.dailyprbulletin.com/immunization-coverage-to-boost-the-growth-of-influenza-vaccines-market-size-and-share-analysis/

Comments

Post a Comment

Popular posts from this blog

Global Fiber Reinforced Concrete Market Opportunity Analysis and Industry Forecast 2028

Image
  Fiber Reinforced Concrete Market A rise in commercial construction activity is anticipated to fuel the market as a result of the economy's improved state. The need for more office and storage space has been driven by the expansion of industries like food and consumer goods, which has had a large positive impact on the construction sector and the demand for paving slabs as long-lasting and attractive flooring. With the majority of the actors involved in the production and manufacture of the raw materials used in the production of paving slabs, product makers have a highly integrated supply chain. The majority of market participants also benefit from a robust direct distribution network that facilitates a seamless flow of products and enables them to build a broader customer base. Having a wide range of customizable products is important while making purchases. The global Fiber Reinforced Concrete Market was valued at US$ 2,330.40 Mn in 2020 and is forecast to reach a value of US$
Read more

Augmented Reality Is Fastest Growing Segment Fueling The Growth Of Air Defense Systems Market

Image
Air Defense Systems Market Market Overview: Air defense systems provides protection against cruise, tactical and strategic ballistic missiles, unmanned aerial vehicles, and aircraft. They consist of radar systems, interceptor missiles, command and control systems and fire control systems. Air defense systems help detect incoming enemy planes, and intercept missiles and other threats before they reach their targets using air-to-air, surface-to-air, and man-portable missiles. Market key trends: One of the major trends in the air defense systems market is the increasing adoption of augmented reality and artificial intelligence. Augmented reality offers 3D digital interfaces to air defense operators and commanders and overlays geographical data and combat intelligence information onto real-world combat scenarios. This enhances situation awareness, minimizes fatigue and improves decision-making. It is increasingly being incorporated into command and control systems, fire control radars and
Read more

The U.S. Sterile Injectables Market Witnessing Tremendous Growth Due to Rising Prevalence of Chronic Disease

Image
U.S. Sterile Injectables Market    Sterile Injectables are compounded medications with sterile components for intravenous administration. They are composed of small molecules, large molecules, and biologics. In 2018, the global sterile injectable market was valued at US$ 357 billion. During the forecast period, the market is expected to grow at a 7.3% CAGR. The market will likely be driven by the growing demand for these medications in developing countries. The U.S. sterile injectables market is expected to expand over the forecast period due to rising product launches are one of the key factors boosting the growth of this market. Many sterile products fail to meet regulatory requirements. Due to the risk involved, a sterile drug product must meet strict standards. Lack of quality assurance in the manufacturing process can result in low-quality medicines. To combat this risk, manufacturers highly trust CMOs to adhere to rigorous quality standards. Manufacturers of sterile injectables a
Read more